Pluto Health Expands Care Model to Medicare, Medicaid and Major Commercial Plans
Pluto Health is now working with Medicare, Medicaid and commercial plans like UnitedHealthcare, Aetna, Blue…
Pluto Health Expands Care Model to Medicare, Medicaid and Major Commercial Plans
Pluto Health is now working with Medicare, Medicaid and commercial plans like UnitedHealthcare, Aetna, Blue Cross Blue Shield, Ambetter and Cigna. The post Pluto Health Expands Care Model to Medicare, Medicaid and Major Commercial Plans appeared first on MedCity News.
A Generalized Risk Adjusted Cost Effectiveness (GRACE) Economic Model for Measuring the Value of Interventions that Delay Mobility Impairment Across Neurological Conditions
That is the title of a new paper out in Value in Health with co-authors Jaehong Kim, Jacob Fajnor, Kyi-Sin Than, Elizabeth S. Mearns , Stacey L. Kowal, Thomas Majda and Jakub P. Hlávka PhD. The abstract is below. Objectives To quantify how incorporating patient risk preferences and severity adjustments affect the value of a…
Genmab to Pay $8B to Get Its Hands on Merus Head & Neck Cancer Drug With Blockbuster Potential
Merus brings Genmab a bispecific antibody in two pivotal studies for head and neck cancer. Genmab, which had long developed drugs under partnerships with larger companies, is now pursuing a strategy of developing and commercializing medications it fully owns. The post Genmab to Pay $8B to Get Its Hands on Merus Head & Neck Cancer…
The Future of Pharmacy Automation: How Capsa Healthcare is Revolutionizing Medication Management
[Sponsored] Pharmacies are under more pressure than ever. Rising prescription volumes, staffing shortages and growing expectations for accuracy and safety have made it clear that the old ways of managing medications are no longer enough. Automation has become the key to keeping pace with modern healthcare. It saves time, reduces errors and helps providers focus…
Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment
Ovarian cancer urgently needs bold, transformative treatment approaches – not just small, incremental improvements. Synthetic, allogeneic iMSCs as tumor-targeting delivery vehicles are an example of how cell biology and engineering may unite and overcome longstanding oncology challenges. The post Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment appeared first on MedCity News.
I Didn’t Dedicate My Career to Medicine to Manage Paperwork — And AI Scribes Won’t Fix That
What clinicians really need today is comprehensive support to offload routine tasks. They need intelligent systems that can proactively highlight relevant patient history before appointments, flag care gaps, and automatically queue up appropriate screening reminders or preventive care protocols. The post I Didn’t Dedicate My Career to Medicine to Manage Paperwork — And AI Scribes…
The Role of Claims Data Management to Support Evidence-Based Healthcare
[Sponsored] In an interview, Will Barnett, Veradigm Senior Solutions Manager, talked about the health tech vendor’s clearinghouse services and how they manage the relationship between payers and providers in support of evidence-based care and value-based care strategies. The post The Role of Claims Data Management to Support Evidence-Based Healthcare appeared first on MedCity News.
Where Jobs Are Scarce, Over 1 Million People Could Dodge Trump’s Medicaid Work Rules
Millions of Medicaid enrollees may have a way out of the new federal work requirement — if they live in a county with high unemployment. By January 2027, President Donald Trump’s far-reaching domestic policy law will require many adult, nondisabled Medicaid enrollees in 42 states and Washington, D.C., to work or volunteer 80 hours a…
In Hepatitis B Vaccine Debate, CDC Panel Sidesteps Key Exposure Risk
The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children. This comes despite a failed attempt to do so at the most recent meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices. Both President Donald Trump and some…
States Target Ultraprocessed Foods in Bipartisan Push
California Republican James Gallagher, the GOP’s former Assembly leader, has often accused the state’s progressive lawmakers of heavy-handed government intrusion, but this year he added his name to a legislative push for healthier school meals. His party followed suit, with all but one Republican voting to send a bill to Democratic Gov. Gavin Newsom that…
